(3-(1-hydroxy-2,2,6,6-tetramethylpiperidin-4-yl)-1,2,3-oxadiazol-3-ium-5-yl)amide hydrochloride

ID: ALA3765045

Chembl Id: CHEMBL3765045

PubChem CID: 127042109

Max Phase: Preclinical

Molecular Formula: C11H21ClN4O2

Molecular Weight: 240.31

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1(C)CC([n+]2cc([NH-])on2)CC(C)(C)N1O.Cl

Standard InChI:  InChI=1S/C11H20N4O2.ClH/c1-10(2)5-8(6-11(3,4)15(10)16)14-7-9(12)17-13-14;/h7-8,12,16H,5-6H2,1-4H3;1H

Standard InChI Key:  SQVXXALCLLWLNQ-UHFFFAOYSA-N

Associated Targets(non-human)

661W (31 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 240.31Molecular Weight (Monoisotopic): 240.1586AlogP: 2.23#Rotatable Bonds: 1
Polar Surface Area: 77.18Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.58CX Basic pKa: 1.92CX LogP: -2.63CX LogD: -2.63
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.76Np Likeness Score: 0.20

References

1. Acharya S, Rogers P, Krishnamoorthy RR, Stankowska DL, Dias HV, Yorio T..  (2016)  Design and synthesis of novel hybrid sydnonimine and prodrug useful for glaucomatous optic neuropathy.,  26  (5): [PMID:26832784] [10.1016/j.bmcl.2015.12.030]

Source